P&G Health Q2 Results | The EBITDA margin stood at 36.4% versus 29.1% year-on-year. Shares of Procter & Gamble Health Ltd ended at ₹5,295.45, up by ₹99.05, or 1.91%, on the BSE.
P&G Health Q2 Results | The EBITDA margin stood at 36.4% versus 29.1% year-on-year. Shares of Procter & Gamble Health Ltd ended at ₹5,295.45, up by ₹99.05, or 1.91%, on the BSE.